Our Strategy

Cornerstone's goal is to become a leading specialty pharmaceutical company that acquires, develops and commercializes significant products for the respiratory market.

Key elements of our strategy to achieve this goal include:

• In-license or acquire rights to under-promoted, patent-protected, branded respiratory pharmaceutical products or late-stage product candidates
There are a number of respiratory products that are currently being under-promoted and that would benefit from Cornerstone's focused sales and marketing expertise.

• Implement life cycle management strategies
Through strategic planning, we can maximize the potential value and competitive position of our currently marketed products, newly-acquired products and product candidates that are currently in development.

• Grow product revenue through a sales force focused on the respiratory market
Concentrating on the respiratory market will help us increase our profile among prescribers, maximize sales and enhance our ability to acquire additional products and product candidates.

• Maintain and strengthen the intellectual property position
A key aspect of this strategy involves proprietary drug delivery and formulation technologies that offer patent protection or market exclusivity.

Through the expertise of our staff, sound strategy, a line of quality products, and an entrepreneurial spirit, we've enjoyed a history of steady growth.